Novo Nordisk shares plummet over 20% on weight-loss drug sale slump
The firm also named Maziar Mike Doustdar as its new CEO on Tuesday, after a gloomy financial forecast spooked investors. ADVERTISEMENT Novo Nordisk shares fell by over 20% on Tuesday after the firm slashed its full-year guid
